SIGN IN
Internship - RNAi Technology Advancement jobs in United States
cer-icon
Apply on Employer Site
company-logo

Novo Nordisk · 13 hours ago

Internship - RNAi Technology Advancement

positionLexington, MA
timeInternship
remoteOnsite
seniorityIntern
money$52K/yr - $89K/yr
Novo Nordisk is a global pharmaceutical company focused on life science innovation. The internship offers hands-on experience in RNAi therapeutics and involves supporting the analysis of experimental data and maintaining laboratory records under the guidance of experienced professionals.
BiotechnologyHealth CareMedicalPharmaceutical
check
Growth OpportunitiesbadNo H1Bnote

Responsibilities

Support the analysis and interpretation of experimental data
Contribute to the preparation of scientific presentations
Learn molecular techniques such as total RNA isolation, qPCR, histology, and protein analysis
Maintain accurate laboratory records
Ensure compliance with relevant safety and quality standards

Qualification

RNAi therapeuticsMolecular techniquesData analysisMicrosoft OfficeProject managementInterpersonal communicationAttention to detailSelf-motivationFlexibilityCollaboration

Required

Must be a current student enrolled at an accredited college or university pursuing at least a bachelor's degree
Strong academic record with a preferred cumulative GPA of 3.0 or higher
Conscientious self-starter with good organizational skills, project management skills and attention to detail
Ability to balance multiple projects and priorities, must be able to multi-task
Strong interpersonal communication and ability to collaborate with teams; must effectively operate independently, across functional lines, and with internal customers
Demonstrated personal initiative, self-motivation, flexibility, adaptability and willingness to learn
Proficient in Microsoft Office Tools including Word, Excel, PowerPoint, etc

Preferred

An in progress undergraduate degree in Biology, Biochemistry, Pre-Med or a related discipline preferred

Company

Novo Nordisk

twittertwittertwitter
Glassdoor4.3
company-logo
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.
dateFounded in 1923
location
Bagsværd, Hovedstaden, DNK
people-size10001+ employees
web-link
https://www.novonordisk.com

Funding

Current Stage
Public Company
Total Funding
$22M
2018-12-05Post Ipo Equity· $22M
1981-07-09IPO

Leadership Team

leader-logo
Lars Fruergaard Jørgensen
President and CEO
linkedin
leader-logo
Lars Sorensen
President & CEO

Recent News

The Motley Fool
Novo Nordisk Plunges Nearly 15% After Earnings. Here's What Investors Need to Know.
2026-02-09
Inc.com
A $49 Ozempic Alternative Just Launched. Novo Nordisk Says It’s ‘Illegal’ and Dangerous
2026-02-09
BioSpace
Novo Nordisk takes the field at the big game, putting Wegovy® pill in consumers’ hands
2026-02-09
Company data provided by crunchbase